Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

International Business Machines Corp. (IBM) Patents Will Pay Dividends In 2-5 Years, Says Chris Carani

International Business Machines Corp. (NYSE:IBM) has just been granted the most number of patents of any technology company by the United States Patent and Trademark Office (USPTO) and that’s likely to benefit the company in the next two to five years, Chris Carani said in a discussion on Bloomberg.

International Business Machines Corp. (NYSE:IBM) was granted 7,500 patents last year by the USPTO, largely a numbers game when talking about this many patents, the McAndrews Held & Malloy Partner said. That is a very large trove of patents even though the USPTO also granted a record number of patents last year, he contextualized.

“The growth in the patents that they are securing does serve their three main business models with respect to outgoing licensing, reducing litigation cost and providing them design freedom. […] Largely, they’re betting across a lot of different technologies. A lot of growth opportunities with respect to cloud computing and cyber security and also cognitive computing. The thought here is that’s going to pay dividends in the next two to five years,” Carani said.

Carani did acknowledge that for three straight years, International Business Machines Corp. (NYSE:IBM) has had negative sales growth. Nonetheless, he said that the company’s three business models are served by having a large amount of patents. The technology veteran and now business process giant is light-years ahead of the second place finisher in the number of patents granted, Carani noted.

International Business Machines, is IBM a good stock to buy, Chris Carani, Alex Barinka,

International Business Machines Corp. (NYSE:IBM) produces $1 billion revenue annually from licenses but they also spend $6 billion on research and development every year.

The discussion also yielded the point that the company needs to monetize effectively on the patents they have rather than just focusing on pumping patent after patent just for the sake of being granted patents.

Prem Watsa’s Fairfax Financial Holdings held about 1.07 million International Business Machines Corp. (NYSE:IBM) shares by the end of September.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!